• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Androgen receptor-driven chromatin looping in prostate cancer.雄激素受体驱动的前列腺癌染色质环化。
Trends Endocrinol Metab. 2011 Dec;22(12):474-80. doi: 10.1016/j.tem.2011.07.006. Epub 2011 Aug 31.
2
Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.雄激素和雌激素可在前列腺癌细胞中转录上调前梯度 2 和 3——两个原型雄激素反应基因。
FEBS J. 2013 Mar;280(5):1249-66. doi: 10.1111/febs.12118. Epub 2013 Feb 13.
3
An AR-ERG transcriptional signature defined by long-range chromatin interactomes in prostate cancer cells.在前列腺癌细胞中,由长程染色质互作定义的 AR-ERG 转录特征。
Genome Res. 2019 Feb;29(2):223-235. doi: 10.1101/gr.230243.117. Epub 2019 Jan 3.
4
Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells.雄激素诱导的非恶性前列腺上皮细胞中的 TMPRSS2:ERG 融合。
Cancer Res. 2010 Dec 1;70(23):9544-8. doi: 10.1158/0008-5472.CAN-10-1638. Epub 2010 Oct 14.
5
Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer.微小RNA-204参与前列腺癌中跨膜丝氨酸蛋白酶2/ETS相关基因调控及雄激素受体重编程
Horm Cancer. 2017 Feb;8(1):28-48. doi: 10.1007/s12672-016-0279-9. Epub 2017 Jan 3.
6
Androgen action in the prostate gland.雄激素在前列腺中的作用。
Minerva Urol Nefrol. 2012 Mar;64(1):35-49.
7
TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.TACC2是一种雄激素反应性细胞周期调节因子,可促进雄激素介导的前列腺癌生长及去势抵抗性生长。
Mol Endocrinol. 2012 May;26(5):748-61. doi: 10.1210/me.2011-1242. Epub 2012 Mar 28.
8
Androgen receptors in early and castration resistant prostate cancer: friend or foe?早期及去势抵抗性前列腺癌中的雄激素受体:是友还是敌?
Hormones (Athens). 2013 Apr-Jun;12(2):224-35. doi: 10.14310/horm.2002.1406.
9
RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.RhoA作为前列腺癌细胞中临床相关雄激素作用的介质。
Mol Endocrinol. 2012 May;26(5):716-35. doi: 10.1210/me.2011-1130. Epub 2012 Mar 28.
10
Androgen signaling and its interactions with other signaling pathways in prostate cancer.雄激素信号传导及其在前列腺癌中与其他信号通路的相互作用。
Bioessays. 2007 Dec;29(12):1227-38. doi: 10.1002/bies.20676.

引用本文的文献

1
Phase Separation Mediated Sub-Nuclear Compartmentalization of Androgen Receptors.相分离介导的雄激素受体亚核区室化。
Cells. 2024 Oct 13;13(20):1693. doi: 10.3390/cells13201693.
2
Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression.FAM3B 与雄激素受体之间反馈调节的丧失驱动前列腺癌的进展。
J Natl Cancer Inst. 2024 Mar 7;116(3):421-433. doi: 10.1093/jnci/djad215.
3
Long-range gene regulation in hormone-dependent cancer.激素依赖性癌症的长程基因调控。
Nat Rev Cancer. 2023 Oct;23(10):657-672. doi: 10.1038/s41568-023-00603-4. Epub 2023 Aug 3.
4
Complexities of Prostate Cancer.前列腺癌的复杂性。
Int J Mol Sci. 2022 Nov 17;23(22):14257. doi: 10.3390/ijms232214257.
5
Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer.揭示激酶在前列腺癌中支撑雄激素信号的作用。
Cells. 2022 Mar 10;11(6):952. doi: 10.3390/cells11060952.
6
Re-Evaluate Fusion Genes in Prostate Cancer.重新评估前列腺癌中的融合基因。
Cancer Inform. 2021 Jun 21;20:11769351211027592. doi: 10.1177/11769351211027592. eCollection 2021.
7
Chromosome Conformation Capture Reveals Two Elements That Interact with the () Transcription Start Site.染色体构象捕获揭示了与 () 转录起始位点相互作用的两个元件。
Int J Mol Sci. 2019 Jan 9;20(2):242. doi: 10.3390/ijms20020242.
8
Novel insights into chromosomal conformations in cancer.癌症中染色体构象的新见解。
Mol Cancer. 2017 Nov 17;16(1):173. doi: 10.1186/s12943-017-0741-5.
9
Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer.微小RNA-204参与前列腺癌中跨膜丝氨酸蛋白酶2/ETS相关基因调控及雄激素受体重编程
Horm Cancer. 2017 Feb;8(1):28-48. doi: 10.1007/s12672-016-0279-9. Epub 2017 Jan 3.
10
Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases.人类磷酸二酯酶4D(PDE4D)亚型组成在原发性前列腺癌中失调,可指示疾病进展和远处转移的发生。
Oncotarget. 2016 Oct 25;7(43):70669-70684. doi: 10.18632/oncotarget.12204.

本文引用的文献

1
Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing.深度测序鉴定人前列腺癌中富集的反复出现的嵌合 RNA。
Proc Natl Acad Sci U S A. 2011 May 31;108(22):9172-7. doi: 10.1073/pnas.1100489108. Epub 2011 May 12.
2
Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.磷酸化-MED1 增强的 UBE2C 基因座环化驱动去势抵抗性前列腺癌生长。
EMBO J. 2011 May 10;30(12):2405-19. doi: 10.1038/emboj.2011.154.
3
How does DNA break during chromosomal translocations?染色体易位过程中 DNA 是如何断裂的?
Nucleic Acids Res. 2011 Aug;39(14):5813-25. doi: 10.1093/nar/gkr223. Epub 2011 Apr 15.
4
Histone modifications and chromatin organization in prostate cancer.前列腺癌中的组蛋白修饰和染色质结构。
Epigenomics. 2010 Aug;2(4):551-60. doi: 10.2217/epi.10.31.
5
The genomic complexity of primary human prostate cancer.原发性人类前列腺癌的基因组复杂性。
Nature. 2011 Feb 10;470(7333):214-20. doi: 10.1038/nature09744.
6
Functional and mechanistic diversity of distal transcription enhancers.远端转录增强子的功能和机制多样性。
Cell. 2011 Feb 4;144(3):327-39. doi: 10.1016/j.cell.2011.01.024.
7
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.视网膜母细胞瘤肿瘤抑制因子控制雄激素信号和人前列腺癌的进展。
J Clin Invest. 2010 Dec;120(12):4478-92. doi: 10.1172/JCI44239. Epub 2010 Nov 22.
8
Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences.基因组重排的触发因素:对基因组、细胞和环境影响的深入了解。
Nat Rev Genet. 2010 Dec;11(12):819-29. doi: 10.1038/nrg2883. Epub 2010 Nov 3.
9
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.利用下一代 RNA 测序技术在人类前列腺癌中发现非 ETS 基因融合。
Genome Res. 2011 Jan;21(1):56-67. doi: 10.1101/gr.110684.110. Epub 2010 Oct 29.
10
Research resource: Genome-wide mapping of in vivo androgen receptor binding sites in mouse epididymis.研究资源:小鼠附睾中体内雄激素受体结合位点的全基因组图谱。
Mol Endocrinol. 2010 Dec;24(12):2392-405. doi: 10.1210/me.2010-0226. Epub 2010 Oct 13.

雄激素受体驱动的前列腺癌染色质环化。

Androgen receptor-driven chromatin looping in prostate cancer.

机构信息

Department of Molecular and Cellular Biochemistry and the Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH 43210, USA.

出版信息

Trends Endocrinol Metab. 2011 Dec;22(12):474-80. doi: 10.1016/j.tem.2011.07.006. Epub 2011 Aug 31.

DOI:10.1016/j.tem.2011.07.006
PMID:21889355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3229688/
Abstract

The androgen receptor (AR) is important for prostate cancer development and progression. Genome-wide mapping of AR binding sites in prostate cancer has found that the majority of AR binding sites are located within non-promoter regions. These distal AR binding regions regulate AR target genes (e.g. UBE2C) involved in prostate cancer growth through chromatin looping. In addition to long-distance gene regulation, looping has been shown to induce spatial proximity of two genes otherwise located far away along the genomic sequence and the formation of double-strand DNA breaks, resulting in aberrant gene fusions (e.g. TMPRSS2-ERG) that also contribute to prostate tumorigenesis. Elucidating the mechanisms of AR-driven chromatin looping will increase our understanding of prostate carcinogenesis and may lead to the identification of new therapeutic targets.

摘要

雄激素受体 (AR) 对前列腺癌的发生和发展至关重要。对前列腺癌中 AR 结合位点的全基因组作图发现,大多数 AR 结合位点位于非启动子区域内。这些远端 AR 结合区域通过染色质环化调节 AR 靶基因(例如 UBE2C),这些基因参与前列腺癌的生长。除了远距离基因调控外,环化还显示出诱导两个基因的空间接近性,否则这些基因沿着基因组序列的位置相距很远,形成双链 DNA 断裂,导致异常基因融合(例如 TMPRSS2-ERG),这也有助于前列腺肿瘤发生。阐明 AR 驱动的染色质环化机制将增加我们对前列腺癌发生的理解,并可能导致新的治疗靶点的鉴定。